Gatifloxacin and Ethionamide as the Foundation for Therapy of Tuberculosis
The use of gatifloxacin (GAT) in combination with ethionamide (ETA) with or without pyrazinamide (PZA) for a 12-week treatment period followed by an 8-week observation period was evaluated in a model of tuberculosis in mice. Mice treated with GAT at 300 mg/kg of body weight in combination with ETA (...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
2003
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166105/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12878502/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.8.2442-2444.2003 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|